Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Enanta Pharmaceuticals, Inc.”

218 pharma patents match "Enanta Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 218
Index total 30,257
Page 8 / 10

Quick answer

This filtered view shows 218 pharmaceutical patents matching "Enanta Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

218 results for “Enanta Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 8211891

    Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  2. US 8188132

    Linked dibenzimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted May 29, 2012 · Expires May 24, 2032

    granted

  3. US 8178531

    Antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted May 15, 2012 · Expires May 10, 2032

    granted

  4. US 8163707

    4′-allene-substituted nucleoside derivatives

    Enanta Pharmaceuticals, Inc. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  5. US 8124584

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  6. US 8101567

    Heteroaryl-containing tripeptide HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

  7. US 8101643

    Benzimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

  8. US 8030307

    Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease

    Enanta Pharmaceuticals, Inc. · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  9. US 7910587

    Quinoxalinyl dipeptide hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  10. US 7906513

    Hydrazide-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  11. US 7728148

    Acyclic oximyl hepatitis C protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  12. US 7718612

    Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 18, 2010 · Expires May 13, 2030

    granted

  13. US 7718769

    Tri-peptide hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 18, 2010 · Expires May 13, 2030

    granted

  14. US 7687459

    Arylalkoxyl hepatitis C virus protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted

  15. US 7662779

    Triazolyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  16. US 7635683

    Quinoxalinyl tripeptide hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 22, 2009 · Expires Dec 17, 2029

    granted

  17. US 7605126

    Acylaminoheteroaryl hepatitis C virus protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted

  18. US 7601709

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  19. US 7582605

    Phosphorus-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted

  20. US 7566719

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  21. US 7468419

    Cyclosporin derivatives for the treatment of immune disorders

    Enanta Pharmaceuticals, Inc. · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  22. US 7419962

    3,6-bicyclolides

    Enanta Pharmaceuticals, Inc. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted

  23. US 7384921

    Polymorphic forms of 6-11 bicyclic ketolide derivatives

    Enanta Pharmaceuticals, Inc. · Granted Jun 10, 2008 · Expires Jun 5, 2028

    granted

  24. US 7368452

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 6, 2008 · Expires May 1, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.